Three drugs for treating Alzheimer's disease - Aricept, Exelon and Reminyl - have been approved for use in the NHS by the National Institute for Clinical Excellence. But patients have to meet a number of strict criteria, including having been assessed by a specialist clinic as having a moderate or mild, rather than severe, condition.